iNtRON Biotechnology, Inc.

Research iNtRON Biotechnology, Inc. (048530.KQ) on Bullrun: market cap KRW 86.03B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Ticker048530.KQ
ExchangeKQ
CountrySouth Korea
SectorHealthcare
IndustryBiotechnology
CurrencyKRW
Market capKRW 86.03B
Financial periodQ2 2026
RevenueKRW 2.03B
Net income-KRW 2.26B
Free cash flow-KRW 687.50M
Gross margin45.8%

Valuation Snapshot

latest market cap is KRW 86.03B.

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-10-18	KRW 86.03B	n/a	n/a	n/a

About iNtRON Biotechnology, Inc.

iNtRON Biotechnology, Inc. engages in the development of novel biopharmaceutical drugs in South Korea. It develops bacteriophage and endolysin based drugs through itLysin and IMPA platform. The company was founded in 1999 and is headquartered in Seongnam-si, South Korea.

Related stock research

South Korea stocks South Korea Healthcare stocks A-Z stock index

Other Healthcare stocks

ORIENT BIO Inc. (002630.KS) GC Corp. (005250.KS) Pharmicell Co., Ltd. (005690.KS) Kanaph Therapeutics Inc. (0082N0.KQ) Samik Pharmaceutical Company LTD. (014950.KQ) HLB Co., Ltd. (028300) Mgen Solutions Co., Ltd. (032790.KQ) Daesung Microbiological Labs. Co., Ltd. (036480.KQ) Seoulin Bioscience Co.,Ltd. (038070.KQ) Hyundai Bioscience Co., Ltd. (048410.KQ) Synergy Innovation Co., Ltd. (048870.KQ) CTCBIO Inc. (060590.KQ)

Frequently asked questions

What is iNtRON Biotechnology, Inc.'s market cap?

iNtRON Biotechnology, Inc.'s market capitalization is KRW 86.03B.